Raju TN (June 2000). “The Nobel chronicles. 1992: Edmond H Fischer (b 1920) and Edwin G Krebs (b 1918)”. 《Lancet》 355 (9219): 2004. doi:10.1016/S0140-6736(05)72951-2. PMID10859071.
PDB1d5r; Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP (October 1999). “Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association”. 《Cell》 99 (3): 323–34. doi:10.1016/S0092-8674(00)81663-3. PMID10555148.
Robinson, M (Jun 2005). “Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases.”. 《International Journal of Clinical Practice》 59 (6): 709–15. doi:10.1111/j.1368-5031.2005.00517.x. PMID15924600.
Gong CX, Grundke-Iqbal I, Iqbal K (August 1994). “Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A”. 《Neuroscience》 61 (4): 765–72. doi:10.1016/0306-4522(94)90400-6. PMID7838376.
Zhande R, Zhang W, Zheng Y, 외. (December 2006). “Dephosphorylation by default, a potential mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2”. 《J. Biol. Chem.》 281 (51): 39071–80. doi:10.1074/jbc.M605251200. PMID17068339.
Hutchinson, DS; Summers, RJ; Bengtsson, T (Sep 2008). “Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease.”. 《Pharmacology & Therapeutics》 119 (3): 291–310. doi:10.1016/j.pharmthera.2008.05.008. PMID18606183.
PDB1d5r; Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP (October 1999). “Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association”. 《Cell》 99 (3): 323–34. doi:10.1016/S0092-8674(00)81663-3. PMID10555148.
FISCHER, EH; KREBS, EG (Sep 1955). “Conversion of phosphorylase b to phosphorylase a in muscle extracts.”. 《The Journal of Biological Chemistry》 216 (1): 121–32. PMID13252012.
Khandelwal, RL; Vandenheede, JR; Krebs, EG (1976년 8월 25일). “Purification, properties, and substrate specificities of phosphoprotein phosphatase(s) from rabbit liver.”. 《The Journal of Biological Chemistry》 251 (16): 4850–8. PMID8449.
Raju TN (June 2000). “The Nobel chronicles. 1992: Edmond H Fischer (b 1920) and Edwin G Krebs (b 1918)”. 《Lancet》 355 (9219): 2004. doi:10.1016/S0140-6736(05)72951-2. PMID10859071.
PDB1d5r; Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP (October 1999). “Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association”. 《Cell》 99 (3): 323–34. doi:10.1016/S0092-8674(00)81663-3. PMID10555148.
Robinson, M (Jun 2005). “Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases.”. 《International Journal of Clinical Practice》 59 (6): 709–15. doi:10.1111/j.1368-5031.2005.00517.x. PMID15924600.
Gong CX, Grundke-Iqbal I, Iqbal K (August 1994). “Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A”. 《Neuroscience》 61 (4): 765–72. doi:10.1016/0306-4522(94)90400-6. PMID7838376.
Zhande R, Zhang W, Zheng Y, 외. (December 2006). “Dephosphorylation by default, a potential mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2”. 《J. Biol. Chem.》 281 (51): 39071–80. doi:10.1074/jbc.M605251200. PMID17068339.
Hutchinson, DS; Summers, RJ; Bengtsson, T (Sep 2008). “Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease.”. 《Pharmacology & Therapeutics》 119 (3): 291–310. doi:10.1016/j.pharmthera.2008.05.008. PMID18606183.
Casiday, Rachel. “Oxidation-Reduction Reactions Experiment”. 《Energy for the Body: Oxidative Phosphorylation》. Department of Chemistry, Washington University. 2013년 4월 24일에 확인함.